
.jpg)
.avif)


.jpg)
.jpg)

.avif)


.jpg)
.jpg)
Designed to support appropriate GLP-1 persistence during periods when treatment is most likely to go off track
Made with clinical responsibility and empathy

Patients begin with a brief onboarding to set context, preferences, and goals
Koa engages patients through natural, voice-based interactions, offering education, check-ins, and gentle guidance between visits
Koa helps patients reflect, recognize patterns, and stay engaged with their care, supporting follow-through alongside their clinical treatment plan.
Side-effect signals, escalation events, and completed handoffs
Longitudinal engagement and follow-through across the treatment journey
Appropriate persistence and treatment continuity over time
Patient experience and provider burden between visits
Real-world barriers that contribute to treatment interruption or discontinuation
NuVee is a health technology company, not a healthcare provider. We build tools designed to support patients between visits by helping them stay engaged, informed, and confident in their care, while remaining aligned with their clinicians and healthcare teams.
No. NuVee and its products are designed to augment, not replace, medical care. Koa works alongside existing treatment plans and encourages patients to stay connected with their clinicians for diagnosis, treatment, and medical decision-making.
Koa is currently designed to support individuals living with obesity, starting with patients using GLP-1 therapies. NuVee’s broader mission is to build tools that can support many people over time, but we are intentionally starting with a focused use case to ensure responsibility, safety, and impact.
Koa is clinically designed by an endocrinologist and obesity medicine physician with safety, scope, and transparency built into the product. Koa supports patients between visits while keeping diagnosis, prescribing, and medical decision-making with the treating care team.